20-Oct-2015 - Merck KGaA

Merck announces Sigma-Aldrich business sale to Honeywell

Transaction is a step towards winning of EU antitrust approval for acquisition of Sigma-Aldrich

Merck announced that Sigma-Aldrich, the U.S. life science company it plans to acquire, agreed to sell parts of its solvents and inorganics business in Europe to Honeywell in fulfilment of commitments made to the European Union in order to win antitrust approval for its $17 billion acquisition of Sigma-Aldrich.

Merck has submitted the agreement with Honeywell to the European Commission, which has to approve the transaction in order for Merck to complete the acquisition of Sigma-Aldrich. The European Commission previously provided conditional approval for the acquisition of Sigma-Aldrich on June 15, 2015. Merck continues to expect closing until the end of November 2015 as announced on September 28, 2015.

“This is another key step towards completing the acquisition of Sigma-Aldrich. Teams at both Merck and Sigma-Aldrich have been working intensely on planning the integration of our two businesses and we are all excited about what this combination will bring for customers and employees,” said Bernd Reckmann, Member of the Executive Board of Merck. “Together we offer life science customers across the world a broader portfolio of products, greater geographic reach and an unmatched combination of industry-leading capabilities.”

Merck and Sigma-Aldrich have agreed to sell parts of Sigma-Aldrich’s solvents and inorganics business in Europe to Honeywell. These include its manufacturing and all related assets in Seelze, Germany, where most of the solvents and inorganics sold by Sigma-Aldrich in Europe are manufactured. In addition, Honeywell will acquire the solvents and inorganics sold by Sigma-Aldrich in Europe under the Sigma-Aldrich brand, worldwide under the Fluka brand and associated trademarks such as Hydranal and Chromasolv as well as a temporary license to the Sigma-Aldrich brand for the supply of solvents and inorganics in the European Economic Area. Further, transitional services to ensure a competitive business and enable Honeywell to build up its own channel to the market have been agreed upon. While the agreement with Honeywell is subject to customary closing conditions, including regulatory review, these approvals do not constitute a precondition for the European Union approval and completion of the Sigma-Aldrich transaction.

Facts, background information, dossiers
  • Merck
  • Sigma-Aldrich
  • acquisitions
More about Merck
More about Honeywell
More about Sigma-Aldrich
  • News

    Merck Completes Sigma-Aldrich Acquisition

    Merck announced the completion of its $ 17 billion acquisition of Sigma-Aldrich, creating one of the leaders in the $ 130 billion global industry. The completion follows last week’s approval from the European Commission, which was the final antitrust condition required to close the Sigma-Al ... more

    Merck Set to Complete Sigma-Aldrich Acquisition

    Merck announced that following the final approval of the European Commission it is set to complete its $17 billion (€13.1 billion) acquisition of Sigma-Aldrich. The European Commission had granted conditional approval to the acquisition of Sigma-Aldrich on June 15, 2015, subject to the dive ... more

    Merck progresses toward completion of Sigma-Aldrich acquisition

    Merck announced that it had obtained all necessary antitrust approvals, with the approval of the European Commission being conditional upon the sale of parts of Sigma-Aldrich’s solvents and inorganics business. Negotiations with potential buyers are in the final stage. Once a binding agreem ... more

  • Companies

    Sigma-Aldrich Chemie GmbH

    more

    Sigma-Aldrich Corp.

    Sigma-Aldrich is a leading Life Science and High Technology company. Its biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high ... more

    Sigma-Aldrich Química, S.A. de C.V.

    Sigma-Aldrich is a leading Life Science and High Technology company. Our biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high ... more